where to inject bpc 157 for hip pain The Hidden Risks of BPC‑157: What Patients Need Know About Contamination and Safety BPC-157 for athletes and injury

The abdomen (at least 2 inches away from the navel) is a common site for subcutaneous NAD+ because it has a good layer of subcutaneous fat and tends to be less sensitive

The addition of glycine provides building blocks for protein synthesis at a time when dietary protein intake often decreases

Preclinical studies in mice demonstrate significant reductions in fat mass and body weight without changes in food intake

Subcutaneous injection is the most common research-context format today, but no published human pharmacokinetic study has formally characterized subcutaneous AOD-9604 (this gap was specifically called out in FDA's December 2024 review)